The OpenAlex profile for Shanfeng Zhu (ORCID 0000-0002-6067-5312) shows 166 works, 5,944 citations, and an h-index of 40, with peak citation years in 2013 (817), 2019 (1,064), and sustained productivity through 2026 (15 works) β a mature, high-output computational biology career. Note that a separate Semantic Scholar record for 'Shan-shan Zhu' (h-index 1, 2 papers on aphasia/NMF) is a different, likely conflated author and should not be attributed to this profile. The primary record spans computational biology, machine learning, and genetics, anchored by high-impact works such as the CAFA3 community challenge in Genome Biology (502 citations), a drugβtarget interaction review in Briefings in Bioinformatics (442 citations), and the CAMI2 metagenomics benchmark in Nature Methods (423 citations) β the latter directly relevant to the metagenomic binning work reviewed here.
VACmap (Nature Communications) introduces a non-linear long-read alignment algorithm that improved downstream complex SV detection F1 by 29.5β73.2% across datasets, resolved gene conversions (SIGLEC11/SIGLEC16, RHCE/RHD), and correctly classified a 109-bp VNTR that minimap2 misclassified, with KIV-2 copy-number estimation showing improved correlation versus biased linear aligners . Benchmarks were extensive (synthetic 30,000 SVs; GIAB HG002βHG004, CHM13, NA19240) and reproducibility is strong (GitHub code, Zenodo DOI). SCGBinner (preprint) applies SCG-guided contrastive learning with Leiden ensemble clustering, recovering 71% more high-quality and 38% more near-complete MAGs than the second-best binner on deep agricultural soil, plus 449 unique novel species versus 33 (SemiBin2) and 60 (MetaBAT2) .
Strengths: rigorous benchmarking against state-of-the-art tools, transparent data/code availability, honest reporting of negative results (all binners failed on strain-madness de novo assemblies), and clinically relevant application loci. Blindspots: VACmap validation is largely human/GIAB-centric with limited non-human genome testing and synthetic-data dependence; SCGBinner's headline soil result rests on a single 250 Gbp sample, limiting cross-site generality; the SCGBinner paper is a preprint (zero recorded citations, no peer review yet), so its claims await independent replication . A VACmap co-author receives industry support from Illumina, PacBio, and Oxford Nanopore β a manageable but disclosable conflict. What would change this assessment: independent replications failing to reproduce SCGBinner gains on held-out long-read metagenomes, or VACmap showing no advantage on non-human or highly error-prone datasets.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.